BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,443,763 | -24.7% | 2,346,934 | 0.0% | 54.70% | +20.7% |
| Q2 2023 | $74,937,603 | +4.3% | 2,346,934 | 0.0% | 45.33% | -10.4% |
| Q1 2023 | $71,863,119 | -21.7% | 2,346,934 | 0.0% | 50.60% | +8.0% |
| Q4 2022 | $91,788,589 | -17.9% | 2,346,934 | 0.0% | 46.86% | +8.8% |
| Q3 2022 | $111,808,000 | +23.1% | 2,346,934 | 0.0% | 43.07% | +5.4% |
| Q2 2022 | $90,850,000 | -32.4% | 2,346,934 | 0.0% | 40.87% | -28.2% |
| Q1 2022 | $134,479,000 | -28.1% | 2,346,934 | 0.0% | 56.91% | +4.4% |
| Q4 2021 | $187,027,000 | -9.0% | 2,346,934 | -0.7% | 54.51% | +118.7% |
| Q3 2021 | $205,573,000 | -32.4% | 2,362,635 | 0.0% | 24.93% | -16.6% |
| Q2 2021 | $304,095,000 | +60.8% | 2,362,635 | 0.0% | 29.88% | -67.5% |
| Q1 2021 | $189,105,000 | +26.9% | 2,362,635 | +129359.5% | 91.90% | -2.7% |
| Q4 2020 | $148,993,000 | – | 1,825 | – | 94.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |